Hernandez M, Neninger E, Ortiz Ra, Santiesteban E, C. K, Amador Rm, Cala M, Bello L, Flores Y, Corella M, A. S, J. Y., Mendoza Ic, Viada C, Robaina M, Valenzuela C, Crombet T, Lage A
{"title":"Racotumomab-alum或Nimotuzumab与多西他赛作为晚期非小细胞肺癌患者切换维持治疗的安全性和有效性:一项III期开放标签随机非效性试验","authors":"Hernandez M, Neninger E, Ortiz Ra, Santiesteban E, C. K, Amador Rm, Cala M, Bello L, Flores Y, Corella M, A. S, J. Y., Mendoza Ic, Viada C, Robaina M, Valenzuela C, Crombet T, Lage A","doi":"10.15761/gos.1000230","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73175,"journal":{"name":"Global surgery (London)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety and Efficacy of Racotumomab-alum or Nimotuzumab versus Docetaxel as switch maintenance therapy for advanced non-small cell lung cancer patients: a Phase III open label randomized non-inferiority trial.\",\"authors\":\"Hernandez M, Neninger E, Ortiz Ra, Santiesteban E, C. K, Amador Rm, Cala M, Bello L, Flores Y, Corella M, A. S, J. Y., Mendoza Ic, Viada C, Robaina M, Valenzuela C, Crombet T, Lage A\",\"doi\":\"10.15761/gos.1000230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73175,\"journal\":{\"name\":\"Global surgery (London)\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global surgery (London)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/gos.1000230\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global surgery (London)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/gos.1000230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Safety and Efficacy of Racotumomab-alum or Nimotuzumab versus Docetaxel as switch maintenance therapy for advanced non-small cell lung cancer patients: a Phase III open label randomized non-inferiority trial.